1. Home
  2. INKT
  3. INKT News

Latest MiNK Therapeutics Inc. (INKT) News on April 19, 2025

INKT

GuruFocus.com

a month ago

MiNK Therapeutics Inc (INKT) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

INKT

Thomson Reuters StreetEvents

a month ago

Q4 2024 Mink Therapeutics Inc Earnings Call

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress
INKT

GlobeNewswire

a month ago

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress

Are MiNK Therapeutics, Inc. (NASDAQ:INKT) Investors Paying Above The Intrinsic Value?
INKT

Simply Wall St.

a month ago

Are MiNK Therapeutics, Inc. (NASDAQ:INKT) Investors Paying Above The Intrinsic Value?

MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
INKT

GlobeNewswire

2 months ago

MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
INKT

GlobeNewswire

2 months ago

MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting

MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
INKT

GlobeNewswire

2 months ago

MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements

MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
INKT

GlobeNewswire

2 months ago

MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting

MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
INKT

GlobeNewswire

3 months ago

MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting
INKT

GlobeNewswire

4 months ago

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting

INKT

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Mink Therapeutics Inc Earnings Call

INKT

GuruFocus.com

5 months ago

MiNK Therapeutics Inc (INKT) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
INKT

GlobeNewswire

5 months ago

MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update

MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report
INKT

GlobeNewswire

5 months ago

MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report

MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024
INKT

GlobeNewswire

5 months ago

MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024

MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors
INKT

GlobeNewswire

6 months ago

MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors

INKT

GuruFocus.com

6 months ago

MiNK Therapeutics Inc (INKT) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors
INKT

GlobeNewswire

6 months ago

MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors

MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024
INKT

GlobeNewswire

7 months ago

MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024

MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference
INKT

GlobeNewswire

8 months ago

MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference

MiNK Reports Second Quarter 2024 Results and Business Update
INKT

GlobeNewswire

8 months ago

MiNK Reports Second Quarter 2024 Results and Business Update

MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
INKT

GlobeNewswire

9 months ago

MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report

MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement
INKT

GlobeNewswire

9 months ago

MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement

MiNK Therapeutics, Inc. (INKT) Upgraded to Strong Buy: Here's What You Should Know
INKT

Zacks

9 months ago

MiNK Therapeutics, Inc. (INKT) Upgraded to Strong Buy: Here's What You Should Know

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
INKT

GlobeNewswire

10 months ago

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
INKT

GlobeNewswire

a year ago

MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting

INKT

GuruFocus.com

a year ago

MiNK Therapeutics Inc (INKT) Q1 2024 Earnings Call Transcript Highlights: Strategic Reductions ...

MiNK Reports First Quarter 2024 Results
INKT

GlobeNewswire

a year ago

MiNK Reports First Quarter 2024 Results

MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
INKT

GlobeNewswire

a year ago

MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer

MiNK to Provide Corporate Update and First Quarter 2024 Financial Report
INKT

GlobeNewswire

a year ago

MiNK to Provide Corporate Update and First Quarter 2024 Financial Report

This MiNK Therapeutics Insider Increased Their Holding In The Last Year
INKT

Simply Wall St.

a year ago

This MiNK Therapeutics Insider Increased Their Holding In The Last Year

MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR
INKT

GlobeNewswire

a year ago

MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR

All You Need to Know About MiNK Therapeutics, Inc. (INKT) Rating Upgrade to Buy
INKT

Zacks

a year ago

All You Need to Know About MiNK Therapeutics, Inc. (INKT) Rating Upgrade to Buy

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript
INKT

Insider Monkey

a year ago

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript

INKT

Thomson Reuters StreetEvents

a year ago

Q4 2023 Mink Therapeutics Inc Earnings Call

MiNK Reports Fourth Quarter and Year-End 2023 Results
INKT

GlobeNewswire

a year ago

MiNK Reports Fourth Quarter and Year-End 2023 Results

MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
INKT

GlobeNewswire

a year ago

MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024
INKT

GlobeNewswire

a year ago

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab
INKT

GlobeNewswire

a year ago

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications
INKT

GlobeNewswire

a year ago

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications

INKT

ACCESSWIRE

a year ago

Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene
INKT

GlobeNewswire

a year ago

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene

Invesco Closed-End Funds Declare Dividends
INKT

PR Newswire

a year ago

Invesco Closed-End Funds Declare Dividends

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%
INKT

Simply Wall St.

a year ago

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%

Broadwind (NASDAQ:BWEN) Shareholders Will Want The ROCE Trajectory To Continue
INKT

Simply Wall St.

a year ago

Broadwind (NASDAQ:BWEN) Shareholders Will Want The ROCE Trajectory To Continue

Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
INKT

GlobeNewswire

a year ago

Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
INKT

Zacks

a year ago

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
INKT

GlobeNewswire

a year ago

Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida

We're Keeping An Eye On International Tower Hill Mines' (TSE:ITH) Cash Burn Rate
INKT

Simply Wall St.

a year ago

We're Keeping An Eye On International Tower Hill Mines' (TSE:ITH) Cash Burn Rate

A2Z Smart Technologies Closes Previously Announced US$4.7 Million Registered Direct Offerings, Inclusive of $1.5 Million Raised in December 2023
INKT

ACCESSWIRE

a year ago

A2Z Smart Technologies Closes Previously Announced US$4.7 Million Registered Direct Offerings, Inclusive of $1.5 Million Raised in December 2023

4 Electronics Semiconductor Stocks to Escape Macro Headwinds
INKT

Zacks

a year ago

4 Electronics Semiconductor Stocks to Escape Macro Headwinds

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INKT

PR Newswire

a year ago

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development
INKT

GlobeNewswire

a year ago

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone
INKT

Simply Wall St.

a year ago

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone

With 61% ownership of the shares, Lincoln Educational Services Corporation (NASDAQ:LINC) is heavily dominated by institutional owners
INKT

Simply Wall St.

a year ago

With 61% ownership of the shares, Lincoln Educational Services Corporation (NASDAQ:LINC) is heavily dominated by institutional owners

Life Science Investor Forum: Presentations Now Available for Online Viewing
INKT

GlobeNewswire

a year ago

Life Science Investor Forum: Presentations Now Available for Online Viewing

7 Promising Penny Stocks With the Potential to Defy Expectations
INKT

InvestorPlace

a year ago

7 Promising Penny Stocks With the Potential to Defy Expectations

What Makes Corvus (CRVS) a New Buy Stock
INKT

Zacks

a year ago

What Makes Corvus (CRVS) a New Buy Stock

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation
INKT

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations
INKT

CNW Group

a year ago

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences
INKT

PR Newswire

a year ago

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences

Is It Too Late To Consider Buying Live Ventures Incorporated (NASDAQ:LIVE)?
INKT

Simply Wall St.

a year ago

Is It Too Late To Consider Buying Live Ventures Incorporated (NASDAQ:LIVE)?

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
INKT

GlobeNewswire

a year ago

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

Positive Signs As Multiple Insiders Buy Investar Holding Stock
INKT

Simply Wall St.

a year ago

Positive Signs As Multiple Insiders Buy Investar Holding Stock

TeraWulf Inc. (NASDAQ:WULF) Analysts Just Slashed Next Year's Estimates
INKT

Simply Wall St.

a year ago

TeraWulf Inc. (NASDAQ:WULF) Analysts Just Slashed Next Year's Estimates

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
INKT

Business Wire

a year ago

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO

FitLife Brands Announces Third Quarter 2023 Results
INKT

GlobeNewswire

a year ago

FitLife Brands Announces Third Quarter 2023 Results

Sagimet Biosciences Presents Preclinical Results Supporting the Therapeutic Potential of its FASN inhibitor in Combination with Semaglutide and a Comprehensive Lipidomic Analysis of Interim FASCINATE-2 Data at AASLD - The Liver Meeting® 2023
INKT

GlobeNewswire

a year ago

Sagimet Biosciences Presents Preclinical Results Supporting the Therapeutic Potential of its FASN inhibitor in Combination with Semaglutide and a Comprehensive Lipidomic Analysis of Interim FASCINATE-2 Data at AASLD - The Liver Meeting® 2023

Aqua Metals, Inc. (NASDAQ:AQMS) Q3 2023 Earnings Call Transcript
INKT

Insider Monkey

a year ago

Aqua Metals, Inc. (NASDAQ:AQMS) Q3 2023 Earnings Call Transcript

INKT

GuruFocus.com

a year ago

MiNK Therapeutics Inc (INKT) Reports Q3 2023 Results: Clinical Progress Amid Financial Challenges

MiNK Therapeutics Reports Third Quarter 2023 Results
INKT

GlobeNewswire

a year ago

MiNK Therapeutics Reports Third Quarter 2023 Results

Full House Resorts Announces Strong Third Quarter Results
INKT

GlobeNewswire

a year ago

Full House Resorts Announces Strong Third Quarter Results

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits
INKT

Business Wire

a year ago

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits

Meridian (NASDAQ:MRBK) Could Be A Buy For Its Upcoming Dividend
INKT

Simply Wall St.

a year ago

Meridian (NASDAQ:MRBK) Could Be A Buy For Its Upcoming Dividend

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
INKT

PR Newswire

a year ago

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)

Share on Social Networks: